- Home
- CRBU vs DIBS Comparison
CRBU vs DIBS Comparison
Compare CRBU & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- DIBS
- Stock Information
- Founded
- CRBU 2011
- DIBS 2000
- Country
- CRBU United States
- DIBS United States
- Employees
- CRBU N/A
- DIBS N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- DIBS Catalog/Specialty Distribution
- Sector
- CRBU Health Care
- DIBS Consumer Discretionary
- Exchange
- CRBU Nasdaq
- DIBS Nasdaq
- Market Cap
- CRBU 93.0M
- DIBS 86.4M
- IPO Year
- CRBU 2021
- DIBS 2021
- Fundamental
- Price
- CRBU $0.77
- DIBS $2.66
- Analyst Decision
- CRBU Strong Buy
- DIBS Hold
- Analyst Count
- CRBU 5
- DIBS 1
- Target Price
- CRBU $10.60
- DIBS N/A
- AVG Volume (30 Days)
- CRBU 1.0M
- DIBS 126.3K
- Earning Date
- CRBU 05-08-2025
- DIBS 05-09-2025
- Dividend Yield
- CRBU N/A
- DIBS N/A
- EPS Growth
- CRBU N/A
- DIBS N/A
- EPS
- CRBU N/A
- DIBS N/A
- Revenue
- CRBU $9,918,000.00
- DIBS $88,740,000.00
- Revenue This Year
- CRBU N/A
- DIBS $4.62
- Revenue Next Year
- CRBU $163.34
- DIBS $6.44
- P/E Ratio
- CRBU N/A
- DIBS N/A
- Revenue Growth
- CRBU N/A
- DIBS 4.93
- 52 Week Low
- CRBU $0.66
- DIBS $2.30
- 52 Week High
- CRBU $4.21
- DIBS $6.20
- Technical
- Relative Strength Index (RSI)
- CRBU 43.66
- DIBS 52.99
- Support Level
- CRBU $0.73
- DIBS $2.41
- Resistance Level
- CRBU $0.91
- DIBS $2.79
- Average True Range (ATR)
- CRBU 0.08
- DIBS 0.19
- MACD
- CRBU 0.01
- DIBS 0.05
- Stochastic Oscillator
- CRBU 24.34
- DIBS 69.05
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.